C116H146F6N12O14 — CID 162062233
(3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(4-methyl-2-oxopiperidin-1-yl)pentanoyl]amino]propanoic acid;(3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(2-oxo-5-propylpiperidin-1-yl)pentanoyl]amino]propanoic acid;(2S)-N-[(1S)-1-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-oxobutyl]-4-methyl-2-[(4R)-2-oxo-4-(trifluoromethyl)piperidin-1-yl]pentanamide;(2S)-4-methyl-N-[(1S)-1-[6-methyl-5-(2-methylphenyl)-3-pyridinyl]-3-oxobutyl]-2-[2-oxo-4-(trifluoromethyl)-1-pyridinyl]pentanamide (PubChem CID 162062233) has the molecular formula C116H146F6N12O14 and a molecular weight of 2046.50 g/mol. Its IUPAC name is (3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(4-methyl-2-oxopiperidin-1-yl)pentanoyl]amino]propanoic acid;(3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(2-oxo-5-propylpiperidin-1-yl)pentanoyl]amino]propanoic acid;(2S)-N-[(1S)-1-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-oxobutyl]-4-methyl-2-[(4R)-2-oxo-4-(trifluoromethyl)piperidin-1-yl]pentanamide;(2S)-4-methyl-N-[(1S)-1-[6-methyl-5-(2-methylphenyl)-3-pyridinyl]-3-oxobutyl]-2-[2-oxo-4-(trifluoromethyl)-1-pyridinyl]pentanamide.
| Compound Name | (3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(4-methyl-2-oxopiperidin-1-yl)pentanoyl]amino]propanoic acid;(3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(2-oxo-5-propylpiperidin-1-yl)pentanoyl]amino]propanoic acid;(2S)-N-[(1S)-1-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-oxobutyl]-4-methyl-2-[(4R)-2-oxo-4-(trifluoromethyl)piperidin-1-yl]pentanamide;(2S)-4-methyl-N-[(1S)-1-[6-methyl-5-(2-methylphenyl)-3-pyridinyl]-3-oxobutyl]-2-[2-oxo-4-(trifluoromethyl)-1-pyridinyl]pentanamide |
|---|---|
| PubChem CID | 162062233 |
| Molecular Formula | C116H146F6N12O14 |
| Molecular Weight | 2046.50 g/mol |
| Exact Mass | 2045.10 |
| IUPAC Name | (3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(4-methyl-2-oxopiperidin-1-yl)pentanoyl]amino]propanoic acid;(3S)-3-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-[[(2S)-4-methyl-2-(2-oxo-5-propylpiperidin-1-yl)pentanoyl]amino]propanoic acid;(2S)-N-[(1S)-1-[5-(2,6-dimethylphenyl)-3-pyridinyl]-3-oxobutyl]-4-methyl-2-[(4R)-2-oxo-4-(trifluoromethyl)piperidin-1-yl]pentanamide;(2S)-4-methyl-N-[(1S)-1-[6-methyl-5-(2-methylphenyl)-3-pyridinyl]-3-oxobutyl]-2-[2-oxo-4-(trifluoromethyl)-1-pyridinyl]pentanamide |
| SMILES | CC(=O)C[C@H](NC(=O)[C@H](CC(C)C)N1CC[C@@H](C(F)(F)F)CC1=O)c1cncc(-c2c(C)cccc2C)c1.CC(=O)C[C@H](NC(=O)[C@H](CC(C)C)n1ccc(C(F)(F)F)cc1=O)c1cnc(C)c(-c2ccccc2C)c1.CCCC1CCC(=O)N(C(CC(C)C)C(=O)N[C@@H](CC(=O)O)c2cncc(-c3c(C)cccc3C)c2)C1.Cc1cccc(C)c1-c1cncc([C@H](CC(=O)O)NC(=O)C(CC(C)C)N2CCC(C)CC2=O)c1 |
| InChI | InChI=1S/C30H41N3O4.C29H36F3N3O3.C29H32F3N3O3.C28H37N3O4/c1-6-8-22-11-12-27(34)33(18-22)26(13-19(2)3)30(37)32-25(15-28(35)36)23-14-24(17-31-16-23)29-20(4)9-7-10-21(29)5;1-17(2)11-25(35-10-9-23(14-26(35)37)29(30,31)32)28(38)34-24(12-20(5)36)21-13-22(16-33-15-21)27-18(3)7-6-8-19(27)4;1-17(2)12-26(35-11-10-22(15-27(35)37)29(30,31)32)28(38)34-25(13-19(4)36)21-14-24(20(5)33-16-21)23-9-7-6-8-18(23)3;1-17(2)11-24(31-10-9-18(3)12-25(31)32)28(35)30-23(14-26(33)34)21-13-22(16-29-15-21)27-19(4)7-6-8-20(27)5/h7,9-10,14,16-17,19,22,25-26H,6,8,11-13,15,18H2,1-5H3,(H,32,37)(H,35,36);6-8,13,15-17,23-25H,9-12,14H2,1-5H3,(H,34,38);6-11,14-17,25-26H,12-13H2,1-5H3,(H,34,38);6-8,13,15-18,23-24H,9-12,14H2,1-5H3,(H,30,35)(H,33,34)/t22?,25-,26?;23-,24+,25+;25-,26-;18?,23-,24?/m0100/s1 |
| InChIKey | YZZLSQSZUVKKMW-LRSDXPNOSA-N |
| XLogP | 21.81 |
| TPSA | 359.63 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 148 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2046.50 |
| LogP ≤ 5 | 21.81 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 17 |